ADAMTS-13 and the platelets activity of the microcoagulation of the blood at the PAI-1 polyporfism

被引：0
|
作者：
Matveeva, Maria [1 ]
Shelest, Ekaterina [1 ]
Popova, Ludmila [1 ]
Patrushev, Lev [2 ]
Bokarev, Igor [1 ]
机构：
[1] IM Sechenov First Moscow State Med Univ, Hosp Therapy 1, Moscow, Russia
[2] Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow, Russia
来源：
THROMBOSIS RESEARCH | 2012年 / 130卷
关键词：
D O I：
10.1016/j.thromres.2012.08.240
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S193 / S193
页数：1
相关论文
共 50 条
  • [31] Neutralization of inhibitory antibodies and restoration of therapeutic ADAMTS-13 activity levels in inhibitor-treated rats by the use of defined doses of recombinant ADAMTS-13
    Plaimauer, B.
    Schiviz, A.
    Kaufmann, S.
    Hoellriegl, W.
    Rottensteiner, H.
    Scheiflinger, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (11) : 2053 - 2062
  • [32] ADAMTS-13 activity and ischemic heart disease: a Mendelian randomization study
    Schooling, C. M.
    Luo, S.
    Johnson, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (11) : 2270 - 2275
  • [33] Clinical utility of ADAMTS-13 testing in suspected thrombotic microangiopathy: an audit of ADAMTS-13 activity assay requests in routine practice from a tertiary hospital
    Garizio, Dominique G.
    Wilgen, Urs
    Williams, Bronwyn A.
    Kennedy, Glen A.
    PATHOLOGY, 2012, 44 (07) : 638 - 641
  • [34] Malignancy is not associated with decreased ADAMTS-13 activity in patients with brain tumors
    Böhm, M
    Gerlach, R
    Scheuer, T
    Stier-Brück, I
    Scharrer, I
    33RD HEMOPHILIA SYMPOSIUM: HAMBURG 2002, 2004, : 269 - 275
  • [35] Association of ADAMTS-13 Activity with Clinical Outcomes in Hospitalized Children with Infections
    Katirlo, Irina
    Prokofjeva, Alina
    Nikulenkova, Anna
    Krievina, Gita
    Tretjakovs, Peteris
    Grope, Ilze
    Balmaks, Reinis
    Gardovska, Dace
    EUROPEAN JOURNAL OF PEDIATRICS, 2017, 176 (11) : 1506 - 1506
  • [36] Plasminogen activator inhibitor type 1 (PAI-1) level and activity at patients with PAI-1 polymorphism
    Shelest, A.
    Matveeva, M. A.
    Popova, L., V
    Patrushev, L., I
    Shuganov, E. G.
    Gneusheva, T. Y.
    Bokarev, I. N.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1173 - 1173
  • [37] PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) IN PLASMA AND PLATELETS
    BOOTH, NA
    SIMPSON, AJ
    CROLL, A
    BENNETT, B
    MACGREGOR, IR
    BRITISH JOURNAL OF HAEMATOLOGY, 1988, 70 (03) : 327 - 333
  • [38] PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) IN PLASMA AND PLATELETS
    BOOTH, NA
    MACGREGOR, IR
    BENNETT, B
    BRITISH JOURNAL OF HAEMATOLOGY, 1988, 68 (04) : 509 - 509
  • [39] Thrombotic Thrombocytopenic Purpura in IgG4-Related Disease With Severe Deficiency of ADAMTS-13 Activity and IgG4 Autoantibody Against ADAMTS-13
    Saeki, Takako
    Ito, Tomoyuki
    Youkou, Akira
    Ishiguro, Hajime
    Sato, Naoko
    Yamazaki, Hajime
    Koike, Tadashi
    Kourakata, Hiroyo
    Ferrari, Silvia
    Scheiflinger, Friedrich
    Narita, Ichiei
    ARTHRITIS CARE & RESEARCH, 2011, 63 (08) : 1209 - 1212
  • [40] PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level
    Morange, PE
    Alessi, MC
    Verdier, M
    Casanova, D
    Magalon, G
    Juhan-Vague, I
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (05) : 1361 - 1365
12345